MADELINE EMMI: Open Payments
NPI 1922785443 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,132 in 108 payments from 9 companies in 2025. Trend: 2023 $114 · 2024 $1,318 · 2025 $3,132
Food & beverage: $3,048Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $1,192 |
| ABBVIE INC. | 22 | $892 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $313 |
| PFIZER INC. | 10 | $236 |
| GENZYME CORPORATION | 4 | $165 |
| SANOFI US SERVICES INC. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $114 |
| Novo Nordisk Inc | 3 | $71 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: TREMFYA, RINVOQ, XIFAXAN, SKYRIZI, VELSIPITY, DUPIXENT, AYVAKIT, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
